
Myomo MYO
$ 0.75
2.73%
Annual report 2025
added 03-09-2026
Country |
|
IPO year |
2017 |
Industry |
Medical devices |
Stock Exchange |
NYSE AMERICAN |
Shares |
41.9 M |
Market Cap[1] |
$ 31.4 M |
EBITDA (LTM) |
$ -12.5 M |
P/E (LTM) |
-2.35 |
P/S (LTM) |
0.79 |
EPS (LTM) |
-0.31 |
Other stocks of industry "Medical devices"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
$ 187.46 | 3.76 % | $ 14 B | Nasdaq Global Select Market,SPB | ||
|
Avinger
AVGR
|
- | -20.74 % | $ 369 K | Nasdaq Capital Market | ||
|
Axonics Modulation Technologies
AXNX
|
- | - | $ 3.31 B | Nasdaq Global Select Market,SPB | ||
|
Aziyo Biologics
AZYO
|
- | 1.37 % | $ 20.5 M | Nasdaq Global Market | ||
|
AxoGen
AXGN
|
$ 34.64 | 3.5 % | $ 1.6 B | Nasdaq Capital Market,SPB | ||
|
BioSig Technologies
BSGM
|
- | 37.08 % | $ 85.7 M | Nasdaq Global Select Market | ||
|
Conformis
CFMS
|
- | - | $ 16.4 M | Nasdaq Capital Market | ||
|
GenMark Diagnostics, Inc.
GNMK
|
- | - | $ 1.77 B | Nasdaq Global Select Market | ||
|
Acutus Medical
AFIB
|
- | -26.83 % | $ 2.62 M | Nasdaq Global Select Market | ||
|
AdaptHealth Corp.
AHCO
|
$ 12.58 | 2.07 % | $ 1.7 B | Nasdaq Capital Market | ||
|
Allied Healthcare Products
AHPI
|
- | 3.58 % | $ 2.21 M | Nasdaq Capital Market | ||
|
Lianluo Smart Limited
LLIT
|
- | 24.59 % | $ 44.8 M | Nasdaq Global Select Market | ||
|
Obalon Therapeutics, Inc.
OBLN
|
- | -5.86 % | $ 30.6 M | Nasdaq Capital Market | ||
|
Bio-Rad Laboratories
BIO
|
$ 293.74 | 1.93 % | $ 8.29 B | NYSE,SPB | ||
|
Cytosorbents Corporation
CTSO
|
$ 0.59 | 1.16 % | $ 36.7 M | Nasdaq Capital Market | ||
|
EDAP TMS S.A.
EDAP
|
$ 3.31 | -0.6 % | $ 124 M | Nasdaq Global Market | ||
|
Bruker Corporation
BRKR
|
$ 40.59 | 3.94 % | $ 6.05 K | Nasdaq Global Select Market,SPB | ||
|
Boston Scientific Corporation
BSX
|
$ 64.25 | 1.69 % | $ 95.1 B | NYSE,SPB | ||
|
Apollo Endosurgery
APEN
|
- | - | $ 475 M | Nasdaq Global Market | ||
|
Cardiovascular Systems
CSII
|
- | 0.15 % | $ 844 M | Nasdaq Global Select Market,SPB | ||
|
ClearPoint Neuro
CLPT
|
$ 10.3 | 2.9 % | $ 292 M | Nasdaq Capital Market | ||
|
Dynatronics Corporation
DYNT
|
- | 14.99 % | $ 929 K | Nasdaq Capital Market | ||
|
Second Sight Medical Products
EYES
|
- | -0.97 % | $ 54.4 M | Nasdaq Capital Market | ||
|
Electromed
ELMD
|
$ 25.14 | 1.19 % | $ 213 M | NYSE American | ||
|
IRIDEX Corporation
IRIX
|
$ 1.04 | 0.97 % | $ 17.6 M | Nasdaq Global Select Market | ||
|
Inogen
INGN
|
$ 6.44 | -0.16 % | $ 171 M | Nasdaq Global Select Market,SPB | ||
|
CryoLife, Inc.
CRY
|
- | -4.14 % | $ 702 M | NYSE,SPB | ||
|
CHF Solutions, Inc.
CHFS
|
- | 1.15 % | $ 34.5 M | Nasdaq Capital Market | ||
|
Soliton, Inc.
SOLY
|
- | -1.42 % | $ 435 M | Nasdaq Global Select Market | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
- | -1.98 % | $ 98.3 M | Nasdaq Capital Market | ||
|
GBS
GBS
|
- | -0.57 % | $ 7.12 M | Nasdaq Global Market | ||
|
Itamar Medical Ltd.
ITMR
|
- | 0.03 % | $ 1.58 B | Nasdaq Global Select Market | ||
|
Misonix, Inc.
MSON
|
- | - | $ 462 M | Nasdaq Global Select Market | ||
|
Neovasc
NVCN
|
- | - | $ 111 M | Nasdaq Capital Market | ||
|
Globus Medical
GMED
|
$ 95.93 | 3.17 % | $ 13 B | NYSE,SPB | ||
|
Helius Medical Technologies
HSDT
|
$ 2.0 | -1.48 % | $ 1.22 M | Nasdaq Capital Market | ||
|
Butterfly Network
BFLY
|
$ 4.45 | 3.86 % | $ 942 M | NYSE | ||
|
Intersect ENT, Inc.
XENT
|
- | - | $ 955 M | Nasdaq Global Market | ||
|
LENSAR
LNSR
|
$ 6.06 | 2.28 % | $ 72.5 M | Nasdaq Capital Market | ||
|
BIOLASE
BIOL
|
- | -13.19 % | $ 166 K | Nasdaq Capital Market | ||
|
OrthoPediatrics Corp.
KIDS
|
$ 17.69 | 4.37 % | $ 415 M | Nasdaq Global Select Market,SPB | ||
|
Delcath Systems
DCTH
|
$ 10.86 | 3.92 % | $ 389 M | Nasdaq Capital Market | ||
|
Inspire Medical Systems
INSP
|
$ 55.87 | 1.73 % | $ 1.64 B | NYSE,SPB | ||
|
CONMED Corporation
CNMD
|
$ 39.49 | 2.68 % | $ 1.23 B | NYSE,SPB | ||
|
LivaNova PLC
LIVN
|
$ 65.41 | 1.29 % | $ 3.57 B | Nasdaq Global Select Market | ||
|
Integer Holdings Corporation
ITGR
|
$ 88.92 | 1.36 % | $ 3.09 B | NYSE,SPB | ||
|
FONAR Corporation
FONR
|
$ 18.7 | -0.05 % | $ 123 M | Nasdaq Capital Market | ||
|
Invacare Corporation
IVC
|
- | - | $ 24.7 M | NYSE | ||
|
Edwards Lifesciences Corporation
EW
|
$ 78.29 | 0.22 % | $ 45.8 B | NYSE,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.